Chemical Name: 4-[(1E)-2-(5,6-Dihydro-5,5-dimethyl-8-phenyl-2-naphthalenyl)ethenyl]-benzoic acid
Biological ActivityBMS 453 is a synthetic retinoid. Retinoic acid receptor β (RARβ) agonist in vivo; RARα and RARγ antagonist in vitro. Inhibits breast cell proliferation by inducing active transforming growth factor β (TGFβ) and causes G1 arrest.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Commitment of mouse embryonic stem cells to the adipocyte lineage requires retinoic acid receptor beta and active GSK3.
Monteiro et al.
Stem Cells Dev., 2009;18:457
RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
Chen et al.
EMBO J., 1995;14:1187
The retinoic acid receptor antagonist, BMS543, inhibits normal breast cell growth by inducing active TGFB and causing cell cycle arrest.
Yang et al.
Citations for BMS 453
The citations listed below are publications that use Tocris products. Selected citations for BMS 453 include:
3 Citations: Showing 1 - 3
Transcriptome analysis of Xenopus orofacial tissues deficient in retinoic acid receptor function.
Authors: Wahl Et al.
BMC Genomics 2018;19:795
BMP and retinoic acid regulate anterior-posterior patterning of the non-axial mesoderm across the dorsal-ventral axis.
Authors: Naylor Et al.
Nat Commun 2016;7:12197
Retinoic acid induces blood-brain barrier development.
Authors: Mizee Et al.
J Neurosci 2013;33:1660
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for BMS 453
There are currently no reviews for this product. Be the first to review BMS 453 and earn rewards!
Have you used BMS 453?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image